- Investing Ideas
- Australian Pharmaceuticals & Biotech Potentially Undervalued Small Caps
Australian Pharmaceuticals & Biotech Potentially Undervalued Small Caps
Results
4
Value score of at least 4 focused on companies with a low market cap.
4 companies
Medical Developments International
Market Cap: AU$43.4m
Manufactures and distributes emergency medical solutions in Australia, Asia, Europe, the United States, and internationally.
MVP
AU$0.39
7D
1.3%
1Y
-34.7%
Botanix Pharmaceuticals
Market Cap: AU$62.9m
Operates as a commercial dermatology company in Australia and the United States.
BOT
AU$0.023
7D
4.5%
1Y
-92.3%
Trajan Group Holdings
Market Cap: AU$49.6m
Develops, manufactures, and sells analytical and life science products and devices in Malaysia, Japan, Australia, New Zealand, the United States, Europe, the Middle East, Africa, and India.
TRJ
AU$0.33
7D
3.2%
1Y
-53.6%
Radiopharm Theranostics
Market Cap: AU$70.9m
A clinical-stage radiotherapeutics company, engages in the research and development of radiopharmaceutical products for diagnostic and therapeutic uses in areas with high unmet medical needs.
RAD
AU$0.02
7D
0%
1Y
-23.1%